Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation-Reference-Cited by-同舟云学术

Glycogen Synthase Kinase 3 Protein Kinase Activity Is Frequently Elevated in Human Non-Small Cell Lung Carcinoma and Supports Tumour Cell Proliferation

Published:2014-12-08 Issue:12 Volume:9 Page:e114725
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Vincent Emma E.,Elder Douglas J. E.,O′Flaherty Linda,Pardo Olivier E.,Dzien Piotr,Phillips Lois,Morgan Carys,Pawade Joya,May Margaret T.,Sohail Muhammad,Hetzel Martin R.,Seckl Michael J.,Tavaré Jeremy M.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. Global cancer statistics, 2002;DM Parkin;CA Cancer J Clin,2005

2. Epidermal growth factor receptor mutations in lung cancer;SV Sharma;Nat Rev Cancer,2007

3. Treatment of non-small-cell lung cancer with erlotinib or gefitinib;VD Cataldo;N Engl J Med,2011

4. Predicting sensitivity of non-small-cell lung cancer to gefitinib: is there a role for P-Akt?;W Pao;J Natl Cancer Inst,2004

5. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic-AMP-dependent protein kinase and phosphorylase kinase;N Embi;Eur J Biochem,1980

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. scRank infers drug-responsive cell types from untreated scRNA-seq data using a target-perturbed gene regulatory network;Cell Reports Medicine;2024-06

2. The Relationship between Circadian Rhythm and Cancer Disease;International Journal of Molecular Sciences;2024-05-28

3. Concurrent targeting of GSK3 and MEK as a therapeutic strategy to treat pancreatic ductal adenocarcinoma;Cancer Science;2024-02-06

4. Biphasic function of GSK3β in gefitinib‑resistant NSCLC with or without EGFR mutations;Experimental and Therapeutic Medicine;2023-09-04

5. Selection of Optimal Cell Lines for High-Content Phenotypic Screening;ACS Chemical Biology;2023-03-15